[1] Chatterjee-Kishore M, van den Akker F, Stark GR. Association of STATs with relatives and friends [J]. Trends Cell Biol,2000,10(3):106-111. [2] 梁又德,周毅,李异雷,等.p-JAK2和p-STAT3在实验性牙移动牙周组织中的表达及意义[J].口腔医学研究, 2014, 30(8):724-727. [3] 李常虹,赵金霞,孙琳,等.JAK2/STAT3信号通路对RANKL诱导的RAW264.7细胞向破骨细胞分化的影响[J].中国骨质疏松杂志, 2013, 19(5):421-425. [4] Stashenko P, Teles R, Souza RD. Periapical inflammatory responses and their modulation [J]. Oral Surg Oral Med Oral Pathol Oral Radiol, 1998, 9(4):498-521. [5] Zhang R, Wang L, Peng B. Activation of p38 mitogen-activated protein kinase in rat periapical lesions [J]. J Endod, 2008, 34(10):1207-1210. [6] 敖翔,王丽娜,王娇娇,等.JAK2-STAT3信号通路在大鼠根尖周炎中表达的相关性研究[J].口腔医学研究, 2017, 33(1):1-5. [7] Stashenko P, Teles R, D'Souza R. Periapical inflammatory responses and their modulation [J]. Crit Rev Oral Biol Med, 1998, 9(4):498-521. [8] Li J, Wang R, Huang SG. Immunomodulatory activity of interleukin-27 in human chronic periapical diseases [J]. AM J Transl Res, 2017, 9(3):1460-1470. [9] Vernal R, Dezerega A, Dutzan N, et al. RANKL in human periapical granuloma: possible involvement in periapical bone destruction [J]. Oral Dis, 2006, 12(3):283-289. [10] Liu L, Zhang C, Hu Y, et al. Protective effect of metformin on periapical lesions in rats by decreasing the ratio of receptor activator of nuclear factor kappa B ligand/osteoprotegerin [J]. J Endod, 2012, 38(7):943-947. [11] Gao B, Chen W, Hao L, et al. Inhibiting periapical lesions through AAV-RNAi silencing of cathepsin K [J]. J Dent Res, 2013, 92(2):180-186. [12] Witthuhn BA, Quelle FW, Silvennoinen O, et al. JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin [J]. Cell, 1993, 74(2):227-236. [13] Watling D, Guschin D, Muller M, et al. Complementation by the protein tyrosine kinase JAK2 of a mutant cell line defective in the interferon-gamma signal transduction pathway [J]. Nature, 1993, 366(6451):166-170. [14] Waters MJ, Brooks AJ. JAK2 activation by growth hormone and other cytokines [J]. Biochem J, 2015, 466(1):1-11. [15] Slootweg MC. Growth hormone and bone [J]. Horm Metab Res, 1993, 25(7):335-343. [16] Agrawal S, Gollapudi S, Su H, et al. Leptin activates human B cells to secrete TNF-alpha, IL-6, and IL-10 via JAK2/STAT3 and p38MAPK/ERK1/2 signaling pathway [J]. J Clin Immunol, 2011, 31(3):472-478. [17] Abroun S, Saki N, Ahmadvand M, et al. STATs: an old story, yet mesmerizing [J]. Cell J, 2015, 17(3):395-411. [18] O'Brien CA, Gubrij I, Lin SC, et al. STAT3 activation in stromal/osteoblastic cells is required for induction of the receptor activator of NF-kappaB ligand and stimulation of osteoclastogenesis by gp130-utilizing cytokines or interleukin-1 but not 1,25-dihydroxyvitamin D3 or parathyroid hormo [J]. J Biol Chem, 1999, 274(27):19301. |